Psyence Biomedical Ltd (PBM)

$0.11

Live

Performance

  • $0.10
    $0.12
    $0.11
    downward going graph

    5.45%

    Downside

    Day's Volatility :11.04%

    Upside

    5.9%

    downward going graph
  • $0.08
    $4.31
    $0.11
    downward going graph

    23.09%

    Downside

    52 Weeks Volatility :98.04%

    Upside

    97.45%

    downward going graph

Returns

PeriodPsyence Biomedical LtdIndex (Russel 2000)
3 Months
-72.34%
0.0%
6 Months
-85.54%
0.0%
1 Year
-95.4%
0.0%
3 Years
-95.4%
-23.0%

Highlights

Market Capitalization
2.6M
Book Value
-$0.82
Earnings Per Share (EPS)
-7.82
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-126.35%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-2.8M
Diluted Eps TTM
-7.82
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

Psyence Biomedical Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Psyence Biomedical Ltd
Psyence Biomedical Ltd
-12.62%
-85.54%
-95.4%
-95.4%
-95.4%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-9.28%
10.06%
24.53%
74.0%
232.45%
Novo Nordisk A/s
Novo Nordisk A/s
-4.54%
-5.72%
21.59%
126.2%
349.01%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
8.87%
102.98%
82.67%
44.83%
241.09%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
5.0%
20.77%
31.37%
158.16%
163.17%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Psyence Biomedical Ltd
Psyence Biomedical Ltd
NA
NA
NA
0.0
0.0
-1.26
NA
-0.82
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
26.41
26.41
1.37
44.9
0.17
0.08
NA
261.41
Novo Nordisk A/s
Novo Nordisk A/s
40.21
40.21
1.81
3.36
0.89
0.23
0.01
25.24
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-2.42
-15.01
0.02
NA
-0.02
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
0.59
0.18
-0.03
0.13
NA
57.26
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Psyence Biomedical Ltd
Psyence Biomedical Ltd
NA
$2.6M
-95.4%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$110.0B
232.45%
26.41
32.04%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$529.8B
349.01%
40.21
34.84%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$38.1B
241.09%
NA
-3.11%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$128.7B
163.17%
32.84
-4.74%

Company Information

Organization
Psyence Biomedical Ltd
Employees
0
CEO
Mr. Jody Aufrichtig
Industry
Miscellaneous

FAQs